Wikipedia -WSS

Wikipedia

author：focus 2025-09-29 01:35:55 - browse：573

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Addiction doctors spar with methadone clinics over legislation

knowledge

WSS

Prosthetic arm enables patients to feel the objects they grip

7 people shot in DC, police say

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Prosthetic arm enables patients to feel the objects they grip

Biohaven protein

PhRMA sues HHS over Medicare drug price negotiation

Wikipedia

Wikipedia

entertainment

Peter Hotez and the public health issue of online harassment

Focused ultrasound for uterine fibroids: an uphill battle

Medicare details structure of new drug price negotiation program

Health insurers say they are turning to AI to cut costs, improve care

Alkermes shareholders re

A new study asks: Are we harming blood donors by taking blood?

How one medical school became remarkably diverse

These geoengineering technologies could help combat the climate crisis, scientists say

Hepatitis C has a cure — but many Americans still lack access to it

Dark money group runs ads on China biotech bill

hotspot

Do more moles mean more problems? Not so, says new study

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Inside the fall of star MIT scientist David Sabatini

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Bacterial infection may be ‘key event’ in endometriosis, study says

4th of July breaks record for highest global temperature ever measured

focus

knowledge

explore

hotspot